SCHEMBL21058542

SCHEMBL21058542

COc1ccccc1-c1cc(Cl)nc(Cl)n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.72
HSP90AB1 P08238 4/20 0.72
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SQOR Q9Y6N5 1/20 0.47
ALDH1A1 P00352 6/20 0.46
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ADORA3 P0DMS8 3/20 0.46
METAP2 P50579 1/20 0.45
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM4E B2RXH2 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
RAB9A P51151 1/20 0.44
MITF O75030 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986102 0.85 HSP90AA1 (0.68) HSP90AA1HSP90AB1KMT2AMEN1L3MBTL1
SCHEMBL3718236 0.84 HSP90AA1 (1.00) HSP90AA1HSP90AB1KDM4EADORA1
SCHEMBL4643760 0.81 HSP90AA1 (0.65) HSP90AA1HSP90AB1KMT2AMEN1SQOR
SCHEMBL28351894 0.80 KDM4E (0.64) HSP90AA1HSP90AB1KMT2AMEN1L3MBTL1
SCHEMBL24122900 0.80 HSP90AA1 (0.62) HSP90AA1HSP90AB1KMT2AMEN1L3MBTL1
SCHEMBL5918453 0.77 HSP90AA1 (0.59) HSP90AA1HSP90AB1L3MBTL1ALDH1A1HPGD
SCHEMBL21058449 0.77 HSP90AA1 (0.46) HSP90AA1HSP90AB1KMT2AMEN1L3MBTL1
SCHEMBL31047268 0.77 HSP90AA1 (0.59) HSP90AA1HSP90AB1L3MBTL1ALDH1A1HPGD
SCHEMBL10646200 0.77 HSP90AA1 (0.59) HSP90AA1HSP90AB1KMT2AL3MBTL1ALDH1A1
SCHEMBL385448 0.77 IDO1 (0.48) HSP90AA1HSP90AB1SMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185456-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2019-06-20 US disclosed
CN-107759571-A Inhibitors of influenza viruses replication and its application method and purposes 广东东阳光药业有限公司 2018-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185456-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF POLRMT, EIF2AK2, POLM HSP90AA1 2980/4885HSP90AB1 2531/4885KMT2A 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.